$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

$gbcs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040535 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$9.203M	$9.045M
YoY Change	-14.79%	-5.6%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.77M	$11.10M
YoY Change	-0.21%	17.45%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$426.2K	$360.0K
YoY Change	-3.14%	-20.64%
% of Gross Profit
Operating Expenses	$12.20M	$11.46M
YoY Change	-0.27%	15.7%
Operating Profit		-$2.414M
YoY Change		648.93%
Interest Expense	-$679.8K	$408.2K
YoY Change	-13.94%	-43.48%
% of Operating Profit
Other Income/Expense, Net	$40.09K	$151.3K
YoY Change	33.63%	-122.63%
Pretax Income	-$3.633M	-$2.260M
YoY Change	65.89%	128.07%
Income Tax
% Of Pretax Income
Net Earnings	-$3.641M	-$2.262M
YoY Change	65.48%	128.31%
Net Earnings / Revenue	-39.56%	-25.01%
Basic Earnings Per Share		-$0.74
Diluted Earnings Per Share	-$1.19	-$0.74
COMMON SHARES
Basic Shares Outstanding	3.055M shares	3.055M shares
Diluted Shares Outstanding		3.055M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.485M	$1.970M
YoY Change	4.55%	0.88%
Cash & Equivalents	$1.485M	$1.972M
Short-Term Investments
Other Short-Term Assets	$1.381M	$1.920M
YoY Change	115.71%	314.8%
Inventory
Prepaid Expenses
Receivables	$2.092M	$2.028M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.957M	$5.915M
YoY Change	-0.12%	7.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.82M	$34.25M
YoY Change	-4.62%	-4.89%
Goodwill	$1.077M	$1.077M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$820.1K	$1.100M
YoY Change	-17.99%	32.26%
Total Long-Term Assets	$35.71M	$36.42M
YoY Change	-4.83%	-3.94%
TOTAL ASSETS
Total Short-Term Assets	$4.957M	$5.915M
Total Long-Term Assets	$35.71M	$36.42M
Total Assets	$40.67M	$42.34M
YoY Change	-4.28%	-2.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.045M	$4.420M
YoY Change	66.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$900.0K	$150.0K
YoY Change	0.0%	0.0%
Long-Term Debt Due	$11.17M	$10.13M
YoY Change	386.33%	394.09%
Total Short-Term Liabilities	$18.15M	$14.72M
YoY Change	164.97%	214.02%
LONG-TERM LIABILITIES
Long-Term Debt	$25.18M	$25.92M
YoY Change	-26.81%	-24.92%
Other Long-Term Liabilities	$312.8K	$300.0K
YoY Change	7.84%	18.16%
Total Long-Term Liabilities	$25.18M	$25.92M
YoY Change	-26.81%	-24.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.15M	$14.72M
Total Long-Term Liabilities	$25.18M	$25.92M
Total Liabilities	$43.64M	$41.66M
YoY Change	5.05%	3.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.75M	-$14.10M
YoY Change	29.11%	22.18%
Common Stock	$153.4K	$152.7K
YoY Change	0.41%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.964M	$676.8K
YoY Change
Total Liabilities & Shareholders Equity	$40.67M	$42.34M
YoY Change	-4.28%	-2.44%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$3.641M	-$2.262M
YoY Change	65.48%	128.31%
Depreciation, Depletion And Amortization	$426.2K	$360.0K
YoY Change	-3.14%	-20.64%
Cash From Operating Activities	-$1.853M	$2.360M
YoY Change	-645.1%	-413.8%
INVESTING ACTIVITIES
Capital Expenditures	-$190.00	-$10.00K
YoY Change	-99.83%	-95.83%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$190.00	$10.00K
YoY Change	-99.83%	-104.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.091M	-1.010M
YoY Change	-236.41%	647.59%
NET CHANGE
Cash From Operating Activities	-1.853M	2.360M
Cash From Investing Activities	190.0	10.00K
Cash From Financing Activities	1.091M	-1.010M
Net Change In Cash	-761.9K	1.360M
YoY Change	117.68%	-220.69%
FREE CASH FLOW
Cash From Operating Activities	-$1.853M	$2.360M
Capital Expenditures	-$190.00	-$10.00K
Free Cash Flow	-$1.853M	$2.370M
YoY Change	-511.81%	-562.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000727346
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits		usd
CY2022Q3	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits		usd
	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt		usd
	GBCS	Other Income From Adjustment Of Debt OtherIncomeFromAdjustmentOfDebt		usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
	GBCS	Increase Decrease In Employee Retention Credit Receivables IncreaseDecreaseInEmployeeRetentionCreditReceivables		usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-15415
	dei	Entity Registrant Name EntityRegistrantName	Selectis Health, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0340206
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8480 E Orchard Rd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 4900
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80111
	dei	City Area Code CityAreaCode	720
	dei	Local Phone Number LocalPhoneNumber	680-0808
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3054587	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1971732	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1420200	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2028484	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2904741	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	656665	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	637680	usd
CY2023Q3	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable	1257980	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	5914861	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4962621	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1099647	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	996400	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34246558	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1076908	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1076908	usd
CY2023Q3	us-gaap	Assets Assets	42337974	usd
CY2022Q4	us-gaap	Assets Assets	42490042	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4415003	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3644001	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	23100	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7500	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	80646	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	257222	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	10127664	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14715767	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6848331	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	461291	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	553775	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25922719	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
CY2023Q3	us-gaap	Security Deposit Liability SecurityDepositLiability	303388	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	291388	usd
CY2023Q3	us-gaap	Liabilities Liabilities	41661211	usd
CY2022Q4	us-gaap	Liabilities Liabilities	41537207	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3054587	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3054587	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3054587	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3054587	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	152728	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13852652	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13768300	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14104617	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13744193	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	676763	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	952835	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42337974	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42490042	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27579941	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	29800207	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9045456	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9581985	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	23633389	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	21192559	usd
CY2023Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7698266	usd
CY2022Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7227718	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7510881	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5329475	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3133797	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1970890	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1167332	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	783524	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	269197	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	252050	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1235446	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1348645	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	357868	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	453608	usd
	us-gaap	Operating Expenses OperatingExpenses	33547048	usd
	us-gaap	Operating Expenses OperatingExpenses	28654203	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	11459128	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9904266	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5967107	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1146004	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2413672	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-322281	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46466	usd
	us-gaap	Interest Expense InterestExpense	1493923	usd
	us-gaap	Interest Expense InterestExpense	1438629	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	408211	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	722226	usd
	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	6866759	usd
CY2023Q3	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	516226	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	256347	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135468	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43325	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	53582	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5629183	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1349627	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	151340	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-668644	usd
	us-gaap	Net Income Loss NetIncomeLoss	-337924	usd
	us-gaap	Net Income Loss NetIncomeLoss	-203623	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2262332	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-360424	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-226123	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2269832	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-998425	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3053970	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3053970	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	952835	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4025176	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4970511	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2100768	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2862243	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	84352	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2262332	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	676763	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3102182	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	255000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	46466	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	37090	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3433238	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	750212	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4175950	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4175950	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	7500	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3177525	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3177525	usd
	us-gaap	Net Income Loss NetIncomeLoss	-337924	usd
	us-gaap	Net Income Loss NetIncomeLoss	-203623	usd
	GBCS	Other Income From Partial Settlement Of Debt OtherIncomeFromPartialSettlementOfDebt	40346	usd
	GBCS	Other Income From Adjustment Of Debt OtherIncomeFromAdjustmentOfDebt	50000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1235446	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1348645	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	343326	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1167332	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	783524	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	291075	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	341724	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-798764	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-616540	usd
	GBCS	Increase Decrease In Employee Retention Credit Receivables IncreaseDecreaseInEmployeeRetentionCreditReceivables	1257980	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	771002	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2837981	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	12000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	24317	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2390891	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-650648	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27891	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	330769	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27891	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-330769	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	501006	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	2286679	usd
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1075491	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	6900	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	22500	usd
	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	84352	usd
	GBCS	Proceeds From Debt Discount Warrants Related Parties ProceedsFromDebtDiscountWarrantsRelatedParties	46466	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1708221	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1051525	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	654779	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2032942	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2416600	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4793101	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3071379	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2760159	usd
	us-gaap	Interest Paid Net InterestPaidNet	1150597	usd
	us-gaap	Interest Paid Net InterestPaidNet	1438629	usd
CY2023Q3	us-gaap	Cash Cash	1971732	usd
CY2022Q3	us-gaap	Cash Cash	1928472	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1099647	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	831687	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3071379	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2760159	usd
	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	22500	usd
	GBCS	Dividends Declared On Series D Preferred Stock DividendsDeclaredOnSeriesDPreferredStock	22500	usd
	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	817749	usd
	GBCS	Financing Of Insurance Premiums FinancingOfInsurancePremiums	581393	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2390891	usd
CY2023Q3	GBCS	Working Capital Deficit WorkingCapitalDeficit	-8800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-337924	usd
	us-gaap	Net Income Loss NetIncomeLoss	-203623	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2262332	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-990925	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	22500	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-360424	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-226123	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2269832	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-998425	usd
	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-337924	usd
	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-203623	usd
CY2023Q3	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-2262332	usd
CY2022Q3	GBCS	Net Income Loss Attributable To Diluted Gross NetIncomeLossAttributableToDilutedGross	-990925	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	22500	usd
	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	22500	usd
CY2023Q3	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	7500	usd
CY2022Q3	GBCS	Preferred Stock Dividends And Other Adjustments Diluted PreferredStockDividendsAndOtherAdjustmentsDiluted	7500	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-360424	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-226123	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2269832	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-998425	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3053970	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3054587	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3054587	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3053970	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3054587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3054587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3053970	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3054587	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2023Q1	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable	6350533	usd
CY2023Q3	GBCS	Income From Employee Retention Credits IncomeFromEmployeeRetentionCredits	516226	usd
CY2023Q3	GBCS	Employee Retention Credits Payable EmployeeRetentionCreditsPayable	5092553	usd
CY2023Q3	GBCS	Employee Retention Credits Receivable EmployeeRetentionCreditsReceivable	1257980	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49254255	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49226364	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13447697	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12212251	usd
CY2023Q3	GBCS	Impairment Property Plant And Equipment ImpairmentPropertyPlantAndEquipment	1560000	usd
CY2022Q4	GBCS	Impairment Property Plant And Equipment ImpairmentPropertyPlantAndEquipment	1560000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34246558	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	35454113	usd
	us-gaap	Depreciation Depreciation	1235446	usd
	us-gaap	Depreciation Depreciation	1348645	usd
CY2023Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	37492320	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	38405315	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	572600	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	810997	usd
CY2023Q3	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	36919720	usd
CY2022Q4	GBCS	Debt Longterm And Shortterm Combined Net Amount DebtLongtermAndShorttermCombinedNetAmount	37594318	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	10127664	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2296830	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	25922719	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34397488	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	84352	usd
CY2023Q3	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	146740	usd
CY2022Q3	us-gaap	Prepaid Expense Other Noncurrent PrepaidExpenseOtherNoncurrent	117716	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	158928	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	643401	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	651954	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	660665	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	55116	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2170064	usd

Files In Submission

Name	View Source	Status
gbcs-20230930_pre.xml	Edgar Link	unprocessable
0001493152-23-040535-index-headers.html	Edgar Link	pending
0001493152-23-040535-index.html	Edgar Link	pending
0001493152-23-040535.txt	Edgar Link	pending
0001493152-23-040535-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gbcs-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gbcs-20230930_cal.xml	Edgar Link	unprocessable
gbcs-20230930_def.xml	Edgar Link	unprocessable
gbcs-20230930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs

2023 Q4 Form 10-Q Financial Statement

#000149315223040535 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS SELECTIS HEALTH, INC. Stock $gbcs

2023 Q4 Form 10-Q Financial Statement

#000149315223040535 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBCS
SELECTIS HEALTH, INC. Stock $gbcs